| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Director | Stock Options | 10,000 | 17 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TELO | Telomir Pharmaceuticals, Inc. | 08 Feb 2024 | 0 | $0 | 3 | General Counsel, Director | 08 Feb 2024, 17:40 |
| MIRA | MIRA PHARMACEUTICALS, INC. | 17 Aug 2023 | 1 | $0 | 4 | Director | 21 Aug 2023, 19:00 |
| MIRA | MIRA PHARMACEUTICALS, INC. | 02 Aug 2023 | 0 | $0 | 3 | Director | 02 Aug 2023, 18:03 |